Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists

Authors

Ryan Murphy

Published

May 24, 2024

Abstract

Orphan GPR52 is emerging as a promising neurotherapeutic target. Optimization of previously reported lead

Supporters

Support the authors with ResearchCoin

Journal

Journal of Medicinal Chemistry

Topics

Chemistry

Medicine

Molecular Biology

Cellular And Molecular Neuroscience

Stereochemistry

DOI

10.1021/acs.jmedchem.4c00856

Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists

Authors

Ryan Murphy

Published

May 24, 2024

Abstract

Orphan GPR52 is emerging as a promising neurotherapeutic target. Optimization of previously reported lead

Supporters

Support the authors with ResearchCoin

Journal

Journal of Medicinal Chemistry

Topics

Chemistry

Medicine

Molecular Biology

Cellular And Molecular Neuroscience

Stereochemistry

DOI

10.1021/acs.jmedchem.4c00856

Paper

Paper

Paper

Paper

Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists

Abstract

Supporters

Journal

Topics

DOI

Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists

Abstract

Supporters

Journal

Topics

DOI